This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.

Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.


1ryo

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 1: Line 1:
-
[[Image:1ryo.gif|left|200px]]
+
{{Seed}}
 +
[[Image:1ryo.png|left|200px]]
<!--
<!--
Line 9: Line 10:
{{STRUCTURE_1ryo| PDB=1ryo | SCENE= }}
{{STRUCTURE_1ryo| PDB=1ryo | SCENE= }}
-
'''Human serum transferrin, N-lobe bound with oxalate'''
+
===Human serum transferrin, N-lobe bound with oxalate===
-
==Overview==
+
<!--
-
A unique feature of the mechanism of iron binding to the transferrin (TF) family is the synergistic relationship between metal binding and anion binding. Little or no iron will bind to the protein without concomitant binding of an anion, physiologically identified as carbonate. Substitution of oxalate for carbonate produces no significant changes in polypeptide folding or domain orientation in the N-lobe of human serum TF (hTF) as revealed by our 1.2A structure. The oxalate is able to bind to the iron in a symmetric bidentate fashion, which, combined with the low pK(a) of the oxalate anion, makes iron displacement more difficult as documented by both iron release kinetic and equilibrium data. Characterization of an N-lobe in which the arginine at position 124 is mutated to alanine reveals that the stabilizing effect of oxalate is even greater in this mutant and nearly cancels the destabilizing effect of the mutation. Importantly, incorporation of oxalate as the synergistic anion appears to completely inhibit removal of iron from recombinant full-length hTF by HeLa S(3) cells, strongly indicating that oxalate also replaces carbonate in the C-lobe to form a stable complex. Kinetic studies confirm this claim. The combination of structural and functional data provides a coherent delineation of the effect of oxalate binding on hTF and rationalizes the results of many previous studies. In the context of iron uptake by cells, substitution of carbonate by oxalate effectively locks the iron into each lobe of hTF, thereby interfering with normal iron metabolism.
+
The line below this paragraph, {{ABSTRACT_PUBMED_15123433}}, adds the Publication Abstract to the page
 +
(as it appears on PubMed at http://www.pubmed.gov), where 15123433 is the PubMed ID number.
 +
-->
 +
{{ABSTRACT_PUBMED_15123433}}
==Disease==
==Disease==
Line 31: Line 35:
[[Category: Mason, A B.]]
[[Category: Mason, A B.]]
[[Category: Iron transport]]
[[Category: Iron transport]]
-
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sat May 3 08:04:22 2008''
+
 
 +
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Mon Jul 28 15:10:19 2008''

Revision as of 12:10, 28 July 2008

Image:1ryo.png

Template:STRUCTURE 1ryo

Contents

Human serum transferrin, N-lobe bound with oxalate

Template:ABSTRACT PUBMED 15123433

Disease

Known disease associated with this structure: Atransferrinemia OMIM:[190000], Iron deficiency anemia, susceptibility to OMIM:[190000]

About this Structure

1RYO is a Single protein structure of sequence from Homo sapiens. Full crystallographic information is available from OCA.

Reference

The oxalate effect on release of iron from human serum transferrin explained., Halbrooks PJ, Mason AB, Adams TE, Briggs SK, Everse SJ, J Mol Biol. 2004 May 21;339(1):217-26. PMID:15123433

Page seeded by OCA on Mon Jul 28 15:10:19 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Retrieved from "http://52.214.119.220/wiki/index.php/1ryo"
Personal tools